Metraipolis › archive › dc_46054df25359

The DARO-flare trial: evaluating the impact of darolutamide on prostate-specific membrane antigen (PSMA) flare and its implications for imaging and staging of… — Europe PMC PMID:42315278

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42315278
DOI
10.1136/bmjopen-2025-115888
License (as archived)
solo-consultazione
Archived
2026-10-08T01:12:19.394Z
SHA-256 of the archived text
44f6a478635725e956f9371c63d756a7a5eb7fd4aa87b8b7325e30e5a57c5cf7
Stable URL of this page
https://metraipolis.com/documento/dc_46054df25359

How to cite

The DARO-flare trial: evaluating the impact of darolutamide on prostate-specific membrane antigen (PSMA) flare and its implications for imaging and staging of… — Europe PMC PMID:42315278 — Europe PMC (en), https://europepmc.org/article/MED/42315278 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_46054df25359 (Metraipolis archive dc_46054df25359, sha256 44f6a478635725e956f9371c63d756a7a5eb7fd4aa87b8b7325e30e5a57c5cf7)
BibTeX
@misc{dc46054df25359,
  title = {The DARO-flare trial: evaluating the impact of darolutamide on prostate-specific membrane antigen (PSMA) flare and its implications for imaging and staging of… — Europe PMC PMID:42315278},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42315278},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_46054df25359; sha256 44f6a478635725e956f9371c63d756a7a5eb7fd4aa87b8b7325e30e5a57c5cf7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42315278. Agents can read the archived copy with the MCP tool read_document.